INNO-GENE SA ZY -10 (WQ3) — Cash Flow Quality Index

Latest as of December 2024: 0.05x

INNO-GENE SA ZY -10 (WQ3) has a Cash Flow Quality Index of 0.05x as of December 2024. Operating cash flow of €147.00K is below net income of €2.91 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore WQ3 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

0.05x
Operating CF / Net Income

Operating Cash Flow

€147.00K
EUR

Net Income

€2.91 Million
EUR

Data as of

Dec 2024
Most recent filing

INNO-GENE SA ZY -10 Cash Flow Quality Index (2021–2024)

Historical Cash Flow Quality Index for INNO-GENE SA ZY -10 across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see INNO-GENE SA ZY -10 cash conversion from operations.

Annual Cash Flow Quality Index for INNO-GENE SA ZY -10 (2021–2024)

Year-by-year earnings quality comparison for INNO-GENE SA ZY -10.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2024 -60.00x €-1.13 Million €18.85K ▼ -171907.8%
2022 0.03x €11.00K €315.00K ▼ -96.9%
2021 1.12x €6.75 Million €6.03 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.